Skip to main content
SpringerLink
Log in

Cancer-related fatigue: can it be due to adrenal suppression secondary to high-dose steroids used as antiemetic?

  • Letter to the editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yennurajalingam S, Frisbee-Hume S, Palmer JL et al (2013) Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol 31(25):3076–82

    Article  CAS  PubMed  Google Scholar 

  2. Scott HR, McMillan DC, Forrest LM et al (2002) The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 87(3):264–7

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Morrow GR, Andrews PL, Hickok JT et al (2002) Fatigue associated with cancer and its treatment. Support Care Cancer 10(5):389–98

    Article  PubMed  Google Scholar 

  4. Lundström S, Fürst CJ (2003) Symptoms in advanced cancer: relationship to endogenous cortisol levels. Palliat Med 17(6):503–8

    Article  PubMed  Google Scholar 

  5. Basch E, Prestrud AA, Hesketh PJ et al (2011) American Society of Clinical Oncology. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29(31):4189–98

    Article  PubMed  Google Scholar 

  6. Henzen C, Suter A, Lerch E et al (2000) Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet 355(9203):542–5

    Article  CAS  PubMed  Google Scholar 

  7. Han HS, Shim YK, Kim JE et al (2012) A pilot study of adrenal suppression after dexamethasone therapy as an antiemetic in cancer patients. Support Care Cancer 20(7):1565–72

    Article  PubMed  Google Scholar 

  8. Meikle AW, Tyler FH (1977) Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med 63(2):200–7

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

No conflict of interest.

Author information

Authors and Affiliations

  1. Medical Oncology Section, Department of Internal Medicine, Yeditepe University Hospital, Devlet yolu, Ankara Caddesi, 102-104, Istanbul, Turkey

    Orhan Onder Eren & Basak Oyan

  2. Department of Internal Medicine, Yeditepe University Hospital, Istanbul, Turkey

    Mehmet Akif Ozturk

Authors
  1. Orhan Onder Eren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehmet Akif Ozturk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Basak Oyan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Orhan Onder Eren.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eren, O.O., Ozturk, M.A. & Oyan, B. Cancer-related fatigue: can it be due to adrenal suppression secondary to high-dose steroids used as antiemetic?. Support Care Cancer 22, 2599–2600 (2014). https://doi.org/10.1007/s00520-014-2124-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-014-2124-4

Keywords

Search

Navigation